-
摘要: 目的 对比全超声引导下实施经导管缘对缘手术与传统介入加超声引导方式对二尖瓣成形效果和钳夹质量的影响。方法 回顾性分析24例正常对照组及全超声引导下行经导管缘对缘手术患者的相关参数,对比两组患者基线资料、二尖瓣成形效果和二尖瓣钳夹相关参数的差异。结果 两组患者基线资料无统计学差异,与对照组相比,全超声引导下行经导管缘对缘手术的二尖瓣成形效果相当,同时二尖瓣钳夹相关参数未见统计学差异。结论 与传统方式相比,全超声引导下进行经导管缘对缘手术在二尖瓣成形相关参数和手术钳夹质量等方面具有相似的临床效果。Abstract: Objective To compare the effect of transcatheter edge-to-edge repair(TEER) surgery on mitral valvuloplasty between full ultrasound guidance and traditional intervention plus ultrasound guidance.Methods The relevant parameters of 24 patients received TEER surgery between control group(under guidance of traditional intervention plus ultrasound guidance) and full ultrasound guided group were retrospectively analyzed. The baseline data of mitral valvuloplasty, the effect of mitral valvuloplasty, and clamp related parameters were compared between the two groups.Results There was no statistical difference in baseline data between the two groups. Compared with the control group, TEER surgery with full ultrasound guidance had the same effect of mitral valvuloplasty, while mitral valve clamp related parameters did not show any statistical difference.Conclusion Compared with control group, TEER surgery under full ultrasound guidance has similar clinical effects with traditional ways in terms of parameters of mitral valvuloplasty and clamp quality.
-
表 1 两组患者TEER手术基线资料
Table 1. Baseline data of TEER operation
X±S, M(P25, P75) 项目 全超声引导组 对照组 P值 年龄/岁 72.67±3.87 71.83±4.86 0.621 男性/例(%) 8(66.67) 7(58.33) 0.999 体重/kg 66.25±9.70 65.42±10.26 0.840 身高/cm 165.7±7.76 165.3±9.13 0.905 BMI/(kg/m2) 24.05±2.30 23.88±2.67 0.875 NYHA心功能分级/例(%) Ⅲ级 2(16.7) 3(25.0) 0.999 Ⅳ级 10(83.3) 9(75.0) 0.999 二尖瓣反流量/级 4(3.25,4.00) 4(4,4) 0.999 二尖瓣瓣口面积/cm2 6.05±0.54 6.03±0.53 0.940 二尖瓣平均压差/mmHg 1.17±0.39 1.25±0.4 0.633 射血分数/% 42.67±4.33 42.08±5.37 0.772 表 2 两组患者TEER术后二尖瓣反流情况
Table 2. Mitral regurgitation after TEER
X±S, M(P25, P75) 全超声引导组 对照组 P值 术后二尖瓣反流量/级 1(1,2) 1(1,2) 0.999 术后二尖瓣瓣口面积/cm2 3.83±0.55 3.79±0.62 0.864 术后二尖瓣平均压差/mmHg 3.08±0.79 3.17±0.83 0.804 术后射血分数/% 47.42±4.54 46.75±5.14 0.740 术后NYHA心功能分级/例(%) Ⅰ级 0 0 0.999 Ⅱ级 8(66.7) 7(58.3) 0.999 Ⅲ级 4(33.3) 5(41.7) 0.999 Ⅳ级 0 0 0.999 表 3 两组患者TEER手术钳夹相关参数
Table 3. Related parameters of TEER surgical clamp
X±S, M(P25, P75) 全超声引导组 对照组 P值 手术时长/min 202.10±41.91 184.60±42.40 0.320 夹子数量/支 1(1,2) 1(1,2) 0.999 夹持失败/例(%) 0 0 0.999 单瓣夹持/例(%) 0 0 0.999 夹子脱落/例(%) 0 0 0.999 转开胸手术/例(%) 0 0 0.999 -
[1] Grayburn PA, Chandrashekhar YS. Functional mitral regurgitation: more questions than answers[J]. JACC Cardiovasc Imaging, 2021, 14(4): 711-714. doi: 10.1016/j.jcmg.2021.03.001
[2] 宋光远, 刘然, 卢志南, 等. 功能性二尖瓣反流的治疗策略[J]. 临床心血管病杂志, 2022, 38(6): 433-438. doi: 10.13201/j.issn.1001-1439.2022.06.002 https://lcxxg.whuhzzs.com/article/doi/10.13201/j.issn.1001-1439.2022.06.002
[3] Bhamra-Ariza P, Muller DW. The MitraClip experience and future percutaneous mitral valve therapies[J]. Heart Lung Circ, 2014, 23(11): 1009-1019. doi: 10.1016/j.hlc.2014.05.021
[4] Magruder JT, Crawford TC, Grimm JC, et al. Managing mitral regurgitation: focus on the MitraClip device[J]. Med Devices(Auckl), 2016, 12(9): 53-60.
[5] Suradi HS, Kavinsky CJ, Hijazi ZM. Percutaneous mitral valve repair: The MitraClip device[J]. Glob Cardiol Sci Pract, 2016, 2016(2): e201617.
[6] Shuvy M, von Bardeleben RS, Grasso C, et al. Safety and efficacy of MitraClip in acutely ill(NYHA Class Ⅳ)patients with mitral regurgitation: Results from the global EXPAND study[J]. ESC Heart Fail, 2023, 10(2): 1122-1132. doi: 10.1002/ehf2.14273
[7] Ramchand J, Miyasaka R. Periprocedural echocardiographic guidance of transcatheter mitral valve edge-to-edge repair using the MitraClip[J]. Cardiol Clin, 2021, 39(2): 267-280. doi: 10.1016/j.ccl.2021.01.009
[8] Lavall D, Hagendorff A, Schirmer SH, et al. Mitral valve interventions in heart failure[J]. ESC Heart Fail, 2018, 5(4): 552-561. doi: 10.1002/ehf2.12287
[9] Flint N, Price MJ, Little SH, et al. State of the art: transcatheter edge-to-edge repair for complex mitral regurgitation[J]. J Am Soc Echocardiogr, 2021, 34(10): 1025-1037. doi: 10.1016/j.echo.2021.03.240
[10] Lin C, Liu L, Liu Y, et al. Recent developments in next-generation occlusion devices[J]. Acta Biomater, 2021, 128: 100-119. doi: 10.1016/j.actbio.2021.04.050
[11] Salvatore T, Ricci F, Dangas GD, et al. Selection of the optimal candidate to MitraClip for secondary mitral regurgitation: beyond mitral valve morphology[J]. Front Cardiovasc Med, 2021, 8: 585415. doi: 10.3389/fcvm.2021.585415
[12] Mitrev L, Desai N, Awad A, et al. Interventional echocardiography of the MV: What the interventionalist wants to know[J]. Semin Cardiothorac Vasc Anesth, 2019, 23(1): 37-47. doi: 10.1177/1089253218778822